Cargando…
A decision impact, decision conflict and economic assessment of routine Oncotype DX testing of 146 women with node-negative or pNImi, ER-positive breast cancer in the UK
BACKGROUND: Tumour gene expression analysis is useful in predicting adjuvant chemotherapy benefit in early breast cancer patients. This study aims to examine the implications of routine Oncotype DX testing in the UK. METHODS: Women with oestrogen receptor positive (ER+), pNO or pN1mi breast cancer w...
Autores principales: | Holt, S, Bertelli, G, Humphreys, I, Valentine, W, Durrani, S, Pudney, D, Rolles, M, Moe, M, Khawaja, S, Sharaiha, Y, Brinkworth, E, Whelan, S, Jones, S, Bennett, H, Phillips, C J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3681004/ https://www.ncbi.nlm.nih.gov/pubmed/23695023 http://dx.doi.org/10.1038/bjc.2013.207 |
Ejemplares similares
-
Low utility of Oncotype DX® in the clinic
por: Ricks‐Santi, Luisel J., et al.
Publicado: (2017) -
Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey
por: Ozmen, Vahit, et al.
Publicado: (2016) -
Clinical use of the Oncotype DX genomic test to guide treatment decisions for patients with invasive breast cancer
por: McVeigh, Terri P, et al.
Publicado: (2017) -
Oncotype DX: Where Does It Stand in India?
por: Batra, Atul, et al.
Publicado: (2019) -
Oncotype DX Recurrence Score in premenopausal women
por: Zhang, Shiliang, et al.
Publicado: (2022)